Tuesday, July 2, 2024
Partly Cloudy, 94°Wind: mph,
Welcome to our new web site!
To give our readers a chance to experience all that our new website has to offer, we have made all content freely avaiable, through October 1, 2018.
During this time, print and digital subscribers will not need to log in to view our stories or e-editions.
(NewsUSA)
- Not long ago, small cell lung cancer was considered the forgotten cancer, and treatment was generally chemotherapy and radiation. But now, there is a new treatment that is showing great promise for patients with small-cell lung cancer. Some doctors say that when it works, it is like hitting a home run in treating small-cell lung cancer.
This exciting new treatment uses the patient's immune system to fight cancer. The treatment, called T-cell engager technology, uses the immune system's T-cells to attack and kill the cancer cell. The FDA approved a new T-cell engager therapy last month.
Dr. Jacob Sands, Thoracic Oncologist at Dana-Farber Cancer Institute, says utilizing T-cell engager technology is like hitting a home run in treating small-cell lung cancer.
Dr. Jacob Sands, Thoracic Oncologist at Dana-Farber Cancer Institute
"Chemotherapy can be like swinging the bat for a single or a double. You're more likely to get a hit, but it doesn't necessarily win the game. What we've seen from the T-cell engagers is particularly exciting because the numbers suggest a more frequent hit. The question is, are those home runs? We don't yet know. Are they triples? We'll have to see," said Dr. Jacob Sands, Thoracic Oncologist at Dana-Farber Cancer Institute in Boston.
LCFA encourages people living with small-cell lung cancer to ask their doctor about the latest treatment options.
For more information on T-cell engager technology and small-cell lung cancer at LCFAmerica.org
